Medivir Aktiebolag
Nasdaq Stockholm · LEI 549300VWDGUX0WMJ1T79· Fiscal year 2025
Staff cost per employee
Not disclosed
Employees
Not disclosed
Quick read
- Operating loss of $9.1M in 2025.
Last 3 years
Operating income
See the share price on Google Finance ↗
Investor metrics
2025
- ROE
- -60.8%
- Debt-to-equity
- 27.0%
- Equity ratio
- 78.7%